Placebo (R = 1)

 

Cholestyramine Treatment (R = 0)

 

Cholesterol
≥ 280 mg/dL
(D = 1)

Cholesterol
< 280 mg/dL
(D = 0)


Total
Placebo

 

Cholesterol
≥ 280 mg/dL
(D = 1)

Cholesterol
< 280 mg/dL
(D = 0)


Total
Treatment

Y = 1

  82

    86

  168

 

  33

    97

  130

Y = 0

669

1081

1750

 

332

1426

1758

Total

751

1167

1918

 

365

1523

1888

Table 1: Definite CHD mortality or myocardial infarction events (Y) in the LRCCPPT according to randomized cholestyramine treatment group (R) and serum cholesterol (mg/dL) at 1 year (D) [27].